I am taking Provera (medroxyprogesterone acetate) and am passing golf‑ball‑size clots; should I stop the medication and get evaluated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Provera and Golf Ball-Size Clots: Immediate Action Required

You should stop Provera immediately and seek urgent medical evaluation for golf ball-size clots, as this represents abnormal heavy bleeding that requires exclusion of serious underlying pathology before any treatment decisions. 1, 2

Why This Is Urgent

  • Golf ball-size clots indicate heavy menstrual bleeding that exceeds normal breakthrough bleeding patterns associated with progestin therapy and warrants immediate clinical assessment 1, 2
  • The FDA drug label for medroxyprogesterone acetate explicitly states: "In cases of breakthrough bleeding, as in all cases of irregular bleeding per vaginum, nonfunctional causes should be borne in mind and adequate diagnostic measures undertaken" 2
  • Passing large clots can indicate significant blood loss that may lead to anemia and hemodynamic instability, requiring urgent evaluation 3

What Must Be Ruled Out First

Before attributing this bleeding to Provera, your clinician must systematically exclude:

  • Pregnancy complications (including miscarriage or ectopic pregnancy) - obtain serum hCG immediately 1, 4
  • Sexually transmitted infections (chlamydia and gonorrhea can cause abnormal bleeding) 1
  • New uterine pathology such as fibroids, polyps, cervical lesions, or endometrial abnormalities 1, 4, 2
  • Coagulation disorders or other systemic causes of heavy bleeding 2

Why Stopping Is the Right Decision

  • Provera can cause breakthrough bleeding, but golf ball-size clots represent excessive bleeding that is not a typical or acceptable side effect 1, 2
  • The CDC guidelines emphasize that unscheduled bleeding requiring intervention should prompt consideration of method change or discontinuation 1
  • Continuing Provera while passing large clots delays proper diagnosis and treatment of potentially serious underlying conditions 1, 4

What Happens Next

Your evaluation should include:

  • Complete blood count to assess for anemia from blood loss 3
  • Pelvic examination and likely transvaginal ultrasound to evaluate for structural abnormalities 1, 2
  • Pregnancy test and STI screening as baseline assessments 1, 4
  • Assessment of hemodynamic stability - large clot passage can indicate significant blood volume loss 3

Important Context About Provera and Bleeding

  • While breakthrough bleeding is common with medroxyprogesterone acetate, particularly in the first 3-6 months, it typically manifests as spotting or light irregular bleeding, not heavy bleeding with large clots 1, 5
  • High-dose oral medroxyprogesterone (60-120 mg) is actually used to treat excessive dysfunctional uterine bleeding, with bleeding cessation typically occurring within 1-4 days 3
  • The fact that you're experiencing heavy bleeding with large clots while on Provera suggests either an inadequate dose for your bleeding pattern or an underlying pathology that requires different management 3

Critical Safety Point

Do not attempt to manage this bleeding at home or wait to see if it improves. The combination of progestin therapy and heavy bleeding with large clots requires immediate medical assessment to prevent complications and identify treatable causes 1, 2, 3

References

Guideline

Management of Unscheduled Bleeding in Contraceptive Users

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents.

The Australian & New Zealand journal of obstetrics & gynaecology, 1997

Guideline

Management of Prolonged Vaginal Bleeding with Hormonal Contraceptives

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Experience with medroxyprogesterone acetate (Depo-Provera) as an injectable contraceptive.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1977

Related Questions

What are the recommendations for using Provera (medroxyprogesterone) in a female patient of reproductive age with an unspecified medical history?
Is the Depo-Provera (medroxyprogesterone) shot recommended for a patient with prolonged menstrual bleeding for 4 months?
Can a Depo Provera (medroxyprogesterone acetate) shot be given earlier than 3 months?
Can Depo‑Provera (medroxyprogesterone acetate) injection cause delayed breast tenderness?
What are the benefits and risks of using the Depo-Provera (medroxyprogesterone acetate) injection as a birth control method for a healthy 35-year-old woman?
In an adult with newly diagnosed diabetes and laboratory results showing positive anti‑GAD‑65 (glutamic acid decarboxylase‑65) antibodies, negative IA‑2 (insulinoma‑associated protein 2) antibodies, negative ZnT8 (zinc transporter 8) antibodies, and elevated C‑peptide, what is the most likely diagnosis and recommended initial management?
Is the patient’s restlessness, insomnia, and auditory hallucinations after abrupt cessation of clonazepam (2 mg daily for 35 years) and low‑dose restart (1 mg) versus quetiapine (Seroquel) initiation due to benzodiazepine withdrawal or antipsychotic‑induced akathisia, and what does CANMAT recommend for management?
What are the indications, dosing, contraindications, and monitoring recommendations for modafinil?
What oral antibiotic is appropriate for outpatient treatment of left‑foot cellulitis in a patient with a penicillin allergy?
What is the recommended dosing regimen, duration, and safety profile for topical nystatin cream in treating superficial cutaneous candidiasis?
After fistula resection with postoperative stool drainage from the wound, should the patient restart Mounjaro (tirzepatide) at discharge?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.